Discover 1,807 paid clinical trials in Escondido, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,807
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
for
Treatment-resistant Depression (TRD)
Location: Oceanside CA, San Diego CA, Phoenix AZ, Irving TX,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70+
Code: NCT07553637
Phase 2, Recruiting
Randomized Withdrawal Study in Patients With Schizophrenia
for
Schizophrenia
Location: Oceanside CA, San Diego CA, Lemon Grove CA,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT06961968
Phase 3, Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: Oceanside CA, La Jolla CA, Las Vegas NV, Visalia CA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06585410
Phase 3, Recruiting
Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
for
Melanoma (Skin), Non-melanomatous Skin Cancer
Location: San Diego CA, Wichita KS, Columbus OH, Philadelphia PA,
Sponsor: Rhode Island Hospital
Sex: All
Age: 18+
Code: NCT00295906
Recruiting
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Location: San Francisco CA, Aurora CO, New Haven CT, Orlando FL,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07193511
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
for
HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
Location: New Haven CT, Orlando FL, Tampa FL, Boston MA,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06998407
Phase 1, Phase 2, Recruiting
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Location: Carlsbad CA, Las Vegas NV, San Antonio TX, Austin TX,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07294170
Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod